Drug Shortage Report for CEREBYX
Report ID | 187772 |
Drug Identification Number | 02230988 |
Brand name | CEREBYX |
Common or Proper name | Cerebyx |
Company Name | SEARCHLIGHT PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | FOSPHENYTOIN SODIUM |
Strength(s) | 75MG |
Dosage form(s) | SOLUTION LIQUID |
Route of administration | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR |
Packaging size | 10ml |
ATC code | N03AB |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2023-03-20 |
Estimated end date | 2023-04-15 |
Actual end date | 2023-04-13 |
Shortage status | Resolved |
Updated date | 2023-04-14 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1600 RUE NOTRE DAME OUEST, SUITE 312 MONTREAL, QUEBEC CANADA H3J 1M1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2023-04-14 | English | Compare |
v4 | 2023-04-13 | French | Compare |
v3 | 2023-04-13 | English | Compare |
v2 | 2023-03-23 | French | Compare |
v1 | 2023-03-23 | English | Compare |
Showing 1 to 5 of 5